Showing results (381-390 of 645) with videos related to

Sort By:
Pageof 65
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Veterinary Immunology and Immunopathology|September 9, 2008
Report of the 3rd Havemeyer workshop on allergic diseases of the Horse, Hólar, Iceland, June 2007E Marti, V Gerber, A D Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Thienopyridine urea inhibitors of KDR kinaseH Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesKeith B Glaser, Junling Li, Patrick A Marcotte, et al.
Journal of Medicinal Chemistry|January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin AVictoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry|October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with In Vivo Target EngagementRobin R Frey, Navendu Jana, Jacob V Gorman, et al.
Science Translational Medicine|October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challengeAlec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Journal of Medicinal Chemistry|September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitorsYujia Dai, Yan Guo, Robin R Frey, et al.
Pageof 65